Kraybill B - Search Results

1

Unnatural ligands for engineered proteins: new tools for chemical genetics.

Bishop A, Buzko O, Heyeck-Dumas S, Jung I, Kraybill B, Liu Y, Shah K, Ulrich S, Witucki L, Yang F, Zhang C, Shokat KM. Bishop A, et al. Among authors: kraybill b. Annu Rev Biophys Biomol Struct. 2000;29:577-606. doi: 10.1146/annurev.biophys.29.1.577. Annu Rev Biophys Biomol Struct. 2000. PMID: 10940260 Review.

2

Structural basis for selective inhibition of Src family kinases by PP1.

Liu Y, Bishop A, Witucki L, Kraybill B, Shimizu E, Tsien J, Ubersax J, Blethrow J, Morgan DO, Shokat KM. Liu Y, et al. Among authors: kraybill b. Chem Biol. 1999 Sep;6(9):671-8. doi: 10.1016/s1074-5521(99)80118-5. Chem Biol. 1999. PMID: 10467133 Free article.

3

Phage-display evolution of tyrosine kinases with altered nucleotide specificity.

Ting AY, Witte K, Shah K, Kraybill B, Shokat KM, Schultz PG. Ting AY, et al. Among authors: kraybill b. Biopolymers. 2001;60(3):220-8. doi: 10.1002/1097-0282(2001)60:3<220::AID-BIP10035>3.0.CO;2-C. Biopolymers. 2001. PMID: 11774228

4

Inhibitor scaffolds as new allele specific kinase substrates.

Kraybill BC, Elkin LL, Blethrow JD, Morgan DO, Shokat KM. Kraybill BC, et al. J Am Chem Soc. 2002 Oct 16;124(41):12118-28. doi: 10.1021/ja0264798. J Am Chem Soc. 2002. PMID: 12371851

5

Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics.

Larochelle S, Batliner J, Gamble MJ, Barboza NM, Kraybill BC, Blethrow JD, Shokat KM, Fisher RP. Larochelle S, et al. Among authors: kraybill bc. Nat Struct Mol Biol. 2006 Jan;13(1):55-62. doi: 10.1038/nsmb1028. Epub 2005 Dec 4. Nat Struct Mol Biol. 2006. PMID: 16327805

6

Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening.

Hu Y, Helm JS, Chen L, Ginsberg C, Gross B, Kraybill B, Tiyanont K, Fang X, Wu T, Walker S. Hu Y, et al. Among authors: kraybill b. Chem Biol. 2004 May;11(5):703-11. doi: 10.1016/j.chembiol.2004.02.024. Chem Biol. 2004. PMID: 15157881

7

Discovery of O-GlcNAc transferase inhibitors.

Gross BJ, Kraybill BC, Walker S. Gross BJ, et al. Among authors: kraybill bc. J Am Chem Soc. 2005 Oct 26;127(42):14588-9. doi: 10.1021/ja0555217. J Am Chem Soc. 2005. PMID: 16231908

8

Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors.

Simov V, Deshmukh SV, Dinsmore CJ, Elwood F, Fernandez RB, Garcia Y, Gibeau C, Gunaydin H, Jung J, Katz JD, Kraybill B, Lapointe B, Patel SB, Siu T, Su H, Young JR. Simov V, et al. Among authors: kraybill b. Bioorg Med Chem Lett. 2016 Apr 1;26(7):1803-8. doi: 10.1016/j.bmcl.2016.02.035. Epub 2016 Feb 19. Bioorg Med Chem Lett. 2016. PMID: 26927423

9

Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor.

Elwood F, Witter DJ, Piesvaux J, Kraybill B, Bays N, Alpert C, Goldenblatt P, Qu Y, Ivanovska I, Lee HH, Chiu CS, Tang H, Scott ME, Deshmukh SV, Zielstorff M, Byford A, Chakravarthy K, Dorosh L, Rivkin A, Klappenbach J, Pan BS, Kariv I, Dinsmore C, Slipetz D, Dandliker PJ. Elwood F, et al. Among authors: kraybill b. J Pharmacol Exp Ther. 2017 May;361(2):229-244. doi: 10.1124/jpet.116.239723. Epub 2017 Feb 13. J Pharmacol Exp Ther. 2017. PMID: 28193636

10

Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium.

Rangarajan R, Kraybill B, Ogundele A, Ketelson HA. Rangarajan R, et al. Among authors: kraybill b. J Ocul Pharmacol Ther. 2015 Oct;31(8):491-7. doi: 10.1089/jop.2014.0164. Epub 2015 Jun 11. J Ocul Pharmacol Ther. 2015. PMID: 26067908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters